4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000096
Chief Executive Officer sold 2,452 shares at $95.71 ($234,681)
From the SEC's structured data for this filing
Trades in this filing
Klein Lawrence Otto · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sale : show line 1 in the form | −2,452 | $95.71 | $234,681 | 923,128 | D |
| Open-market sales · 2,452 sh · avg $95.71 · $234,681 | ||||||
Loading xslF345X06/form4.xml…